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Background
Breast cancer is one of the main health problems in
women in Mexico. Breast cancer treatment needs to be
multidisciplinary. Surgical treatment has presented dra-
matics changes. Skin-sparing mastectomy (SSM) greatly
enhances the aesthetic results of breast reconstruction, is
not yet a standard technique for breast cancer treatment,
although it is shown as an advanced and promising pro-
cedure. The objective of this study was to present the expe-
rience of the National Cancer Institute of Mexico in skin-
sparing mastectomy in patients with breast cancer.
Materials and methods
A retrospective review was performed in patients who
underwent SSM and immediate breast reconstruction
from April 1997 to December 2004. Records were ana-
lyzed for each patient, including type of tumors and treat-
ment, overall survival, disease free survival and aesthetic
results.
Results
During April 1997 and December 2004, SSM with imme-
diate reconstruction was performed in 91 patients (4
patients with bilateral cancer and 10 underwent prophy-
lactic mastectomy in the other breast). The mean age was
40 years (22–58 years). Most patients were pre-menopau-
sal (77%). Five patients (5.5%) have contralateral breast
cancer. The histological diagnoses was invasive ductal car-
cinoma in the most patients (74.7%). Systemic neoadju-
vant chemotherapy was performed in 32.9% (30 patients)
and radiotherapy preoperative in 7.7% (7 patients). Most
of half of patient (58) underwent adjuvant chemotherapy
(63.3%) and 27 patients received adjuvant radiotherapy
(29.6%). In most of the patients (50) TRAM flap was the
reconstruction method employed, tissue expander-
implant in second place (27 patients), implant in 23
patients and latissimus flap and implant in 5 patients. The
complication rate was 36% (38 cases in 105 procedures),
28 minor and 9 majors. Of 7 patients with preoperative
radiotherapy 6 underwent complications (3 majors) and
11 of 27 patients with adjuvant radiotherapy have any
type of complication (4 majors). The aesthetic result was
in 63.3% this was excellent or good; 14.4% regular; 7.7%
poor and 14.4% not reported. The follow-up mean was 66
months (13–100 months), four recurrences were detected
(4.4%); 3 systemic and 1 local-regional and systemic.
Conclusion
SSM is an oncological safety procedure in breast cancer
early with recurrence rates similar to non-SSM, the com-
plication rates were comparable to conventional mastec-
tomy, being mostly associated to radiotherapy.
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